400
Participants
Start Date
March 31, 2025
Primary Completion Date
July 31, 2025
Study Completion Date
August 4, 2025
Antimicrobial photodynamic therapy (aPDT) nasal decolonization device
aPDT is a technique that employs a specific wavelength of light to activate a photosensitizer substance. Once activated, this photosensitizer reacts with surrounding molecules to produce radicals and reactive oxygen species. When activated in the presence of microorganisms, these molecules serve to disrupt membrane structure and protein cross-linking, leading to their death.
Royal Columbian Hospital, New Westminster
Lead Sponsor
Collaborators (1)
Ondine Biomedical Inc.
INDUSTRY
Royal Columbian Hospital Foundation
OTHER
Fraser Health
OTHER